Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and ...
SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that eight abstracts highlighting new data from its chronic hepatitis B (CHB) and chronic hepatitis
Source: eagletribune.com